Brief: China Shineway Pharmaceutical Group says profit attributable for HY expected to fall
03/08/2017 10:13
Aug 3 (Reuters) - China Shineway Pharmaceutical Group Ltd
2877.HK
* Profit attributable to owners of company for six months
ended 30 june 2017 is expected to decrease by approximately 35%
* Expected result due to to decreases of average selling
price and sales volume of group's pharmaceutical products
Source text for Eikon: ID:nHKSwx9ZL
Further company coverage: 2877.HK
(bangalore.newsroom@thomsonreuters.com)
Recent news on China Shineway Pharmaceutical
See all newsBrief: China Shineway Pharmaceutical Posts Q1 Turnover Of RMB624 MLN
Brief: China Shineway Pharmaceutical Declares 2026 First Interim Dividend RMB43 Cents Per Share
Brief: China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
Brief: China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
Brief: China Shineway Pharmaceutical Group Posts H1 Net Income RMB 626.5 Mln